Article
01 Jun 2026
Health Canada Issues Revised Biosimilar Guidance Reducing Clinical Evidence Requirements For Biosimilar Approval
AUTHORS CONTENT
Article
20 Jun 2025
Health Canada Proposes To Remove Phase III Trial Requirement From Biosimilar Approval Pathway
Article
13 Oct 2022
Patented Medicines Prices Review Board (PMPRB) Releases New Draft Guidelines
Article
30 Dec 2021
Amendments To The Patented Medicines Regulations Delayed Six Months, Until July 1, 2022
Article
21 Dec 2021
Biologic And Biosimilar Litigation – Is A Proactive Approach Your Best Defence?
Article
08 Dec 2021
Patent Litigation Trends: The Future Of Biologics?
Article
15 Oct 2021
Patent Applications - Consider Requesting Examination Now To Avoid Proposed Excess Claim Fees
Article
23 Jul 2021
Proposed Amendments To Canadian Patent Rules Introduce "Excess" Claim Fees And Limit Number Of Office Actions
Article
01 Jul 2021
Amendments To The Patented Medicines Regulations Delayed By A Further Six Months, Until January 1, 2022
Article
06 May 2021
PMPRB Seeks Feedback On Guideline Monitoring And Evaluation Plan
Article
29 Apr 2021
Proposed Amendments To Listing Patents On Canada's Patent Register
Article
22 Apr 2021
Federal Court Of Appeal Defers To Health Canada On Interpretation Of Csp Regulations
Article
26 Feb 2021
Global Perspectives - Preliminary Injunctions In Life Sciences
Article
03 Feb 2021
Second Medical Use Patents Part 2 - Verifying Validity
Article
25 Jan 2021
Second Medical Use Patent Series: Understanding Infringement And Enforcement (Video)
Article
04 Jan 2021
Amendments To The Patented Medicines Regulations Delayed By 6-months, Until July 1, 2021
Article
25 Jun 2020
Lifecycle Of A Smart Idea: Patent Strategy - Optimising Life Sciences Patents (Video)
Article
10 Jun 2020
A Message From Our Global Life Sciences Group (Video)
Article
09 Oct 2018
The USMCA: What Does It Mean For Patents And The Pharmaceutical Industry?
Article
16 Feb 2018
From TPP To CPTPP: Suspensions To IP Provisions